Jason Turowski, MD

• Graduated Summa Cum Laude from Drexel University in 2003
• Graduated Alpha Omega Alpha from Drexel University College of Medicine in 2007
• Completed the Osler Medical Residency at the Johns Hopkins Hospital by 2010, published in Chest
• Completed a Pulmonary and Critical Care Fellowship at the University of Pennsylvania 2010-2013
• Completed an Advanced Lung Disease and Lung Transplant Fellowship at Penn in 2012-2013
• Conducted a clinical trial assessing the role of antioxidants in patients with cystic fibrosis
• Pulse oximetry standardization project medical director for the Cleveland Clinic enterprise
• Appointed Associate Director of the Cleveland Clinic Adult Cystic Fibrosis Program
• Appointed Medical Director of the Cleveland Clinic Pulmonary Transplant Fellowship

• Management of patients with cystic fibrosis
• Management of cystic fibrosis patients into lung transplant medicine
• Quality improvement in the cystic fibrosis lung transplant transition
• Leadership training - Timeless cohort 1

• Summa Cum Laude from Drexel University
• Alpha Omega Alpha
• Ronald J. Caputo Award 2007 for humanitarianism and excellence in the care of medical patients
• Osler Scholar
• First Advanced Lung Disease, Lung Transplant Fellow in Penn Medicine's history

See publications for this provider. (Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)

Cleveland Clinic physicians and scientists collaborate with industry to advance medical breakthroughs. These partnerships help commercialize discoveries for public benefit while maintaining scientific integrity. To ensure transparency and minimize potential bias, Cleveland Clinic reviews these relationships and publicly discloses when physicians/scientists receive significant compensation for consulting, serve in fiduciary roles, receive royalties, or hold equity interests related to their work. We manage potential conflicts through approval processes, annual reporting, and targeted management plans.

As of 2026-01-08, Dr. Turowski has reported no financial relationship with industry that is applicable to this listing.

In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by Cleveland Clinic. To learn more about Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.

Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers' discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.

* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.